Einsiedel Lloyd J, Fernandes Liselle A, Woodman Richard J
Department of Medicine, Alice Springs Hospital, Alice Springs, NT, Australia.
Med J Aust. 2008 May 19;188(10):568-71. doi: 10.5694/j.1326-5377.2008.tb01791.x.
To compare infection-related mortality rates and pathogens isolated for Indigenous and non-Indigenous adult patients at Alice Springs Hospital (ASH).
DESIGN, PARTICIPANTS AND SETTING: Retrospective study of inhospital deaths of adults (patients aged > or = 15 years) associated with an infection during a medical or renal admission to ASH between 1 January 2000 and 31 December 2005.
Admission- and population-based infection-related mortality rates and mortality rate ratios (MRRs) for Indigenous versus non-Indigenous adults.
There were 513 deaths, of 351 Indigenous and 162 non-Indigenous patients. For Indigenous patients, 60% of deaths were infection-related, compared with 25% for non-Indigenous patients (P < 0.001). The admission-based infection-related MRR for Indigenous versus non-Indigenous adults was 2.2 (95% CI, 1.6-3.1) (15.3 v 6.8 deaths per 1000 admissions; P < 0.001). After adjusting for age and year of death, the population-based infection-related MRR was 11.3 (95% CI, 8.0-15.8) overall (351 v 35 deaths per 100,000 population; P < 0.001) and 31.5 (95% CI, 16.1-61.8) for patients aged < 60 years. The median age of patients who died with an infection was 49 (interquartile range [IQR], 38-67) years for Indigenous and 73 (IQR, 58-80) years for non-Indigenous patients (P < 0.001). For Indigenous patients, 56% of infection-related deaths were associated with bacterial sepsis, with half of these due to enteric organisms. Other deaths followed chronic hepatitis B infection, invasive fungal infections and complications of strongyloidiasis.
Indigenous patients at ASH are 11 times more likely than non-Indigenous patients to die with an infectious disease. This racial disparity reflects the ongoing socioeconomic disadvantage experienced by Indigenous Australians.
比较爱丽丝泉医院(ASH)本土和非本土成年患者的感染相关死亡率及分离出的病原体。
设计、参与者与研究背景:对2000年1月1日至2005年12月31日期间因感染在ASH接受内科或肾脏科治疗的成年住院患者(年龄≥15岁)的院内死亡情况进行回顾性研究。
基于入院患者和总体人群的本土与非本土成年患者感染相关死亡率及死亡率比(MRRs)。
共有513例死亡病例,其中本土患者351例,非本土患者162例。本土患者中,60%的死亡与感染相关,而非本土患者为25%(P<0.001)。本土与非本土成年患者基于入院人数的感染相关MRR为2.2(95%CI,1.6 - 3.1)(每1000例入院患者中分别有15.3例和6.8例死亡;P<0.001)。在对年龄和死亡年份进行校正后,总体基于人群的感染相关MRR为11.3(95%CI,8.0 - 15.8)(每10万人口中分别有351例和35例死亡;P<0.001),60岁以下患者为31.5(95%CI,16.1 - 61.8)。感染相关死亡的本土患者中位年龄为49岁(四分位间距[IQR],38 - 67岁),非本土患者为73岁(IQR,58 - 80岁)(P<0.001)。对于本土患者,56%的感染相关死亡与细菌性败血症有关,其中一半由肠道微生物引起。其他死亡原因包括慢性乙型肝炎感染、侵袭性真菌感染和类圆线虫病并发症。
ASH的本土患者死于传染病的可能性是非本土患者的11倍。这种种族差异反映了澳大利亚本土居民持续面临的社会经济劣势。